Cargando…
2798. Difficult to treat GES and KPC harboring Pseudomonas aeruginosa: Evaluation of in vivo efficacy of ß-lactam/ß-lactamase inhibitor humanized exposure vs. in vitro efficacy
BACKGROUND: GES and KPC harboring Pseudomonas aeruginosa (PSA) pose a challenge clinically as therapeutic alternatives are limited, and clinical data is scarce. Murine models provide translational data that can provide insight into therapeutic alternatives, and assist in clinical guidance. Herein, w...
Autores principales: | Ruiz, Victor H, Gill, Christian, Nicolau, David P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678086/ http://dx.doi.org/10.1093/ofid/ofad500.2409 |
Ejemplares similares
-
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases
por: Abouelhassan, Yasmeen, et al.
Publicado: (2023) -
1241. In Vivo Efficacy of Meropenem Against Metallo-ß-Lactamase (MBL)-Harboring Pseudomonas aeruginosa and Correlation to In Vitro Susceptibility Upon Addition of EDTA
por: Kois, Abigail K, et al.
Publicado: (2021) -
2170. It takes two to tango: ß-lactam/ß-lactamase inhibitor combinations targeting metallo-ß-lactamase (MBL)- producing Klebsiella pneumoniae.
por: Kaur, Jan Naseer, et al.
Publicado: (2023) -
Low level ß-lactamase production in methicillin-resistant staphylococcus aureus strains with ß-lactam antibiotics-induced vancomycin resistance
por: Hirao, Yuriko, et al.
Publicado: (2012) -
2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability
por: Jeon, Albert B., et al.
Publicado: (2017)